A comprehensive evaluation of pulmonary hypertension in end-stage renal disease patients. Specific attention is paid to the purported mechanisms of pulmonary hypertension development, as well as ESRD-specific risk factors. The presentation concludes with a detailed analysis of various therapeutic options and remaining unanswered questions.
A comprehensive review of drug dosing in patients with kidney dysfunction. Special attention is made to the mathematical calculations of volume of distribution and medication clearance on hemodialysis and peritoneal dialysis.
A collection of clinical trials addressing the potential benefits of raloxifene (Evista®) in the primary and secondary prevention of osteoporosis in end-stage renal disease patients.
A brief examination of the common issues facing elderly CKD and ESRD patients. Special focus is made to palliative care issues in this unique patient population.
This observational study assesses the prognostic ability of serum cystatin C in determining the need for dialysis or the outcome of death in acute renal failure patients. The prognostic potential for Cystatin C is compared against that for serum creatinine, urine output, and blood urea nitrogen.